According to UnivDatos, the rising life sciences R&D investment, expansion of functional genomics research, growing focus on precision and rare disease therapeutics, increasing demand for cost-effective target validation in drug discovery, strengthening academic–industry collaborations, advancements in RNA delivery and stability technologies, and improving biomedical research infrastructure drive the Southeast Asia RNAi Technology market. As per the “Southeast Asia RNAi Technology Market” report, the market was valued at ~USD 80.20 million in 2024, growing at a CAGR of about 16.25% during the forecast period from 2025 to 2033 to reach USD million by 2033. 

The Southeast Asia RNAi Technology market is defined by a combination of world leaders in life sciences and local players that facilitate research, drug discovery, and genomics applications. These companies play a critical role in enabling RNA interference by providing premium-quality reagents, platforms, and tailor-made solutions. Their existence enhances local supply chains and facilitates faster technological transfer across both academic and commercial ecosystems. The competitive strategies are moving towards regional expansion, alliances, and application-specific innovation.

1.    GenScript

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. GenScript's proprietary OptimumRNAi technology offers 2nd generation siRNA design tool, which can efficiently reduce off-target results and enhance the knockout rate. GenScript's siRNA design tool is effective and easy to handle. 

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/southeast-asia-rnai-technology-market?popup=report-enquiry

2.    Integrated DNA Technologies, Inc. (Danaher Corporation)

Integrated DNA Technologies, Inc. provides genomics solutions, including manufacturing oligonucleotides and offering next-generation sequencing services for research use. The company supplies products and services such as oligonucleotides, readymade primers, oligos for cDNA generation, and tools for identifying single-nucleotide polymorphisms and chromosome events. It offers next-generation sequencing solutions under the xGen NGS portfolio, including products for whole-genome sequencing, targeted hybridization capture, and sequencing workflows compatible with DNBSEQ platforms. The company provides synthetic arrayed library formats, predesigned CRISPR-Cas9 guide RNAs, and customized assays for research in areas such as solid tumors, blood cancer, and genetic diseases. Manufacturing services support CRISPR therapeutics projects and gene expression analysis, and technical support is available for product selection and compatibility. The company serves researchers at pharmaceutical and biopharmaceutical companies, academic institutions, and organizations involved in genomics, biotechnology, and clinical development research. IDT's default unified RNAi design parameters incorporate the following criteria for RNAi selection and ranking from the target sequence of interest.

3.    Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in the biotechnology market, providing innovative solutions for research, diagnostics, and applied sciences. The company offers a wide range of products and services, including laboratory equipment, reagents, and software, designed to enhance scientific discovery and accelerate healthcare advancements. Thermo Fisher supports various sectors, including pharmaceuticals, academia, and environmental analysis, through its commitment to quality and technological innovation. Their comprehensive portfolio addresses critical needs in molecular biology, genomics, proteomics, and cell culture. Thermo Fisher Scientific developed the Invitrogen RNAi portfolio to support in vitro and in vivo research. The products also scale from single gene studies to libraries for high-throughput screening applications and mid-scale production.

4.    Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. The product offers molecular biology & functional genomics, gene editing, RNAi, and single clones.

5.    Bio Basic Asia Pacific Pte Ltd.

Bio Basic Asia Pacific Pte Ltd is a life science and biotechnology laboratory supplier based in Singapore. They offer a range of products and services including life science products, biochemicals, next generation sequencing, gene services, peptide synthesis, DNA markers, and protein markers. Bio Basic Asia Pacific provides a wide variety of chemically modified siRNA products, such as 2’-hydroxymethylation modification, Phosphorothioate modification, Fluoro modification, etc. With advanced technology for siRNA synthesis, our production team has addressed the concern of siRNA stability in transfection experiments via chemical modification.=. In collaboration with Cohesion Biosciences, Bio Basic Asia Pacific now provides two types of siRNA products, standard siRNA and chemically-modified siRNA, with various modifications of siRNA available in accordance to our customer’s requirements.

Related Reports:-

MicroRNA (miRNAs) Market: Current Analysis and Forecast (2021-2027)

NGS Sample Preparation Market: Current Analysis and Forecast (2021-2027)

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/